[Seminar] Building a Drug Discovery Ecosystem and Promoting Clinical Trials and Research Initiatives

basic information

【Lecture Overview】 In recent years, the issue of drugs that have been approved in Europe and the United States but are not developed in Japan (drug loss) has become apparent, raising concerns that innovative pharmaceuticals may not be provided in Japan. In response, both the public and private sectors in Japan are working together to advance discussions aimed at (1) strengthening the country's drug discovery capabilities, (2) delivering the latest pharmaceuticals to the public quickly, and (3) establishing a social system that sustains the cycle of investment and innovation. This lecture will provide an overview of the government's efforts to build a drug discovery ecosystem in Japan, as well as a detailed explanation of the current status of clinical trials and studies conducted by the Ministry of Health, Labour and Welfare, along with various measures to promote them. 【Lecture Topics】 ■ Current status of drug loss in Japan ■ Policy direction for building a drug discovery ecosystem in Japan ■ Current status and challenges regarding clinical trials in Japan ■ Initiatives by the Ministry of Health, Labour and Welfare to promote clinical trials ■ Related Q&A session ■ Business card and information exchange meeting

Price information

[Course Fee] 1 person: 37,320 yen (including tax) Benefits: One additional person from the same organization can attend for free per registered participant (registration required) *For those affiliated with local public organizations, up to 2 people can attend for 11,000 yen (including tax / venue and live streaming only)

Delivery Time

Applications/Examples of results

For more details, please refer to the PDF document or feel free to contact us.